A panel of monoclonal antibodies with varying pilus specificities ranging from cross-reacting to type-specific has been used to investigate the role of conserved and variable antigenic domains in the adhesion of gonococci to human epithelial cells. The binding of 125I-labelled α pili from strain P9 to buccal epithelial cells was inhibited by three type-specific but not by two cross-reacting antibodies. Four type-specific antibodies inhibited the binding of γ pili while the two cross-reacting antibodies were again without effect. The virulence of the variants P9-2 (α pili) and P9-35 (γ pili) for Chang conjunctiva epithelial cells was similarly reduced only in the presence of relevant type-specific antibodies. These results indicate the importance of variable antigenic domains in the adhesion of gonococci to human epithelial cells.
BrintonC. C.,
BryanJ.,
DillonJ.-A.,
GuerinaN.,
JacobsonL. J.,
LabikA.,
LeeS.,
LevineA.,
LimS.,
McmichaelJ.,
PolenS.,
RogersK.,
ToA.C.-C.,
ToS.C.-M.1978; Uses of pili in gonorrhea control: role of bacterial pili in diseases, purification and properties of gonococcal pili, and progress in the development of a gonococcal pilus vaccine for gonorrhea. In Immunobiology of Neisseria gonorrhoeae pp. 155–178 Edited by BrooksG. F.,
GotschlichE. C.,
HolmesK. K.,
SawyerW. D.,
YoungF. E.
Washington, D.C.: American Society for Microbiology;
BrintonC. C.,
WoodS. W.,
BrownA.,
LabikA. M.,
BryanJ. R.,
LeeS. W.,
PolenS. E.,
TramontE. C.,
SadoffJ.,
ZollingerW.1982; The development of a neisserial pilus vaccine for gonorrhoea and meningococcal meningitis. In Seminars in Infectious Disease, vol. IV, Bacterial Vaccines pp. 140–159 Edited by WeinsteinL.,
FieldsB. N.,
RobbinsJ. B.,
HillJ. C.,
SadoffG.
New York: Thieme-Stratton;
BuchananT. M.,
SiegelM. S.,
ChenK. C. S,
PearceW. A.1982; Development of a vaccine to prevent gonorrhoea. In Seminars in Infectious Disease, vol. IV, Bacterial Vaccines pp. 160–164 Edited by
WeinsteinL.,
FieldsB. N.,
RobbinsJ. B.,
HillJ. C.,
SadoffG.
New York: Thieme-Stratton;
DiazJ.-L.,
HeckelsJ. E.1982; Antigenic variation of outer membrane protein II in colonial variants of Neisseria gonorrhoeae P9. Journal of General Microbiology 128:585–591
DuckworthM.,
JacksonD.,
ZakK.,
HeckelsJ. E.1983; Structural variations in pili expressed during gonococcal infection. Journal of General Microbiology 129:1593–1596
GubishE. R.,
ChenK. C. S,
BuchananT. M.1982; Attachment of gonococcal pili to lectin-resistant clones of Chinese hamster ovary cells. Infection and Immunity 37:189–194
LambdenP. R.,
HeckelsJ. E.,
McbrideH.,
WattP. J.1981a; The identification and isolation of novel pilus types produced by variants of Neisseria gonorrhoeae P9 following selection in vivo. FEMS Microbiology Letters 10:339–341
LambdenP. R.,
RobertsonJ. N.,
WattP. J.1981b; The preparation and properties of α and β pili from variants of Neisseria gonorrhoeae P9. Journal of General Microbiology 124:109–117
SchoolnikG. K.,
TaiJ.-Y.,
GotschlichE. C.1982; The human erythrocyte binding domain of gonococcal pili. In Seminars in Infectious Disease, vol. IV, Bacterial Vaccines pp. 172–180 Edited by WeinsteinL.,
FieldsB. N.,
RobbinsJ. B.,
HillJ. C.,
SadoffG.
New York: Thieme-Stratton;
SwansonJ.1973; Studies on gonococcus infection. IV. Pili, their role in attachment of gonococci to tissue culture cells. Journal of Experimental Medicine 137:571–589
VirjiM.,
HeckelsJ. E.1983; Antigenic cross reactivity of Neisseria pili : investigations with type and species-specific monoclonal antibodies. Journal of General Microbiology 129:2761–2768
VirjiM.,
EversonJ. S.,
LambdenP. R.1982; Effect of anti-pilus antisera on virulence of variants of Neisseria gonorrhoeae for cultured epithelial cells. Journal of General Microbiology 128:1095–1100
VirjiM.,
HeckelsJ. E.,
WattP. J.1983; Monoclonal antibodies to gonococcal pili : studies on antigenic determinants on pili from variants of strain P9. Journal of General Microbiology 129:1965–1973
WardM. E.,
WattP. J.,
RobertsonJ. N.1974; The human fallopian tube: a laboratory model for gonococcal infection. Journal of Infectious Diseases 129:650–659